Keep in mind that the uterine fibroid trial concluded in December. Could be that the data has been viewed...if positive it's going to run a heck of a lot more. You're getting into serious blockbuster territory at that point.
Abbott not going to make any kind of annoucement on P2 Fibroids so we will all be quessing what the results are.
Elagolix for Endo P3 top line results where scheduled for Y/E 2013 so they have slipped into 2014????
IMO, Abbott has not been the best partner for NBIX but it was the only partner that was willing to do UF along with Endo. Their womens health franchise is second to none but there have been significant delays in the development of Elagolix..
NBIX commented that they didn't know if Abbvie would discuss the UF data. If its positive you can bet they'll be presenting it at conferences and profiling it more aggressively on their analyst materials. Abbvie is all about their pipeline so I don't expect them to sit on solid data...they'll be promoting it. It's NBIX that can't release any data.
Its looks like per several post on the Investor Village NBIX board this trial is still recruiting and we won't see results untill later this year. Abbvie increased the trial population seize for whatever reason.